NASDAQ : AVBP

ArriVent BioPharma, Inc. — Earnings Estimates

$30.16 USD

-$1.57 (-4.95%)

Volume
751.58K
Average Volume
550.8K
Market Capitalization
$1.4B
P/E Ratio
-8.54
Dividend Yield
0.00%
Price Target
$45.00
Year High
$35.83
Year Low
$16.10
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$13.95

Annual earnings financials

AVBP financial data with annual/quarterly toggle

AVBP GAAP EPS - Annual & Quarterly

AVBP Sales Revenue - Annual & Quarterly

AVBP Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

AVBP Estimated and Actual Revenue by Quarter
AVBP Estimated and Actual EPS by Quarter
AVBP Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 1 - - - - - -
2027-09-30 1 - - - - - -
2027-06-30 1 - - - - - -
2027-03-31 1 - - - - - -
2026-12-31 1 - - - - - -
2026-09-30 1 - - - - - -
AVBP Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 1 -34.48M -34.48M -34.48M - - -
2027-09-30 1 -41.35M -41.35M -41.35M - - -
2027-06-30 1 -44.05M -44.05M -44.05M - - -
2027-03-31 1 -43.04M -43.04M -43.04M - - -
2026-12-31 1 -49.45M -49.45M -49.45M - - -
2026-09-30 1 -47.38M -44.6M -45.99M - - -
AVBP Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 1 22.6M 22.6M 22.6M 1 -0.765 -0.765 -0.765
2027-09-30 1 12.6M 12.6M 12.6M 1 -0.9175 -0.9175 -0.9175
2027-06-30 1 9.7M 9.7M 9.7M 1 -0.9775 -0.9775 -0.9775
2027-03-31 1 9.7M 9.7M 9.7M 1 -0.955 -0.955 -0.955
2026-12-31 1 6.05M 6.05M 6.05M 1 -1.09728 -1.09728 -1.09728
2026-09-30 1 800K 800K 800K 5 -1.05141 -0.98957 -1.02049